> > > > > >

Rachel Ochotny

Name: Rachel Ochotny
Address: 6505 Market Street, Building A Suite 1210, Boardman, OH, 44512, US
Telephone: (330) 543-3343
Price range: $

Akron Children's Pediatric Palliative Care, Boardman Office

(330) 543-3343

6505 Market Street, Building A Suite 1210 Boardman, OH 44512

Find out more about Rachel Ochotny, MD

Report Incorrect Info

About

Rachel Ochotny

Rachel Ochotny, MD joined Akron Children’s in 2024 as a Pediatric Palliative Care Physician. A graduate of Jacobs School of Medicine and Biomedical Sciences in Buffalo, New York, she completed a residency in pediatrics at St. Louis Children’s Hospital in St. Louis, Missouri. Dr. Ochotny is board certified in General Pediatrics and is a member of the American Academy of Hospice and Palliative Medicine.

Website https://www.akronchildrens.org/people/Rachel-Ochotny.html?y_source=1_MTA4MDc3NzUzMC01MTAtbG9jYXRpb24ud2Vic2l0ZQ==

Primary Specialty

Hospice

Practice Akron Children's Pediatric Palliative Care, Boardman

Not Accepting New Patients

Insurances Accepted https://www.akronchildrens.org/pages/Insurance-Information.html

Office Name Akron Children's Pediatric Palliative Care, Boardman

Languages English

Map and Directions

6505 Market Street, Building A Suite 1210, Boardman, OH 44512

Services Rachel Ochotny is a Hospice office located in Boardman, OH. A Hospice cares for terminally ill patients.

Please call Rachel Ochotny at (330) 543-3343 to schedule an appointment in Boardman, OH or get more information. Additional Services Nursing Home, Pediatrician

Consumer Feedback

Add a Review

There are no recent reviews. Be the first!

Wellness.com does not provide medical advice, diagnosis or treatment nor do we verify or endorse any specific business or professional listed on the site. Wellness.com does not verify the accuracy or efficacy of user generated content, reviews, ratings, or any published content on the site. Content, services, and products that appear on the Website are not intended to diagnose, treat, cure, or prevent any disease, and any claims made therein have not been evaluated by the FDA. Use of this website constitutes acceptance of the Terms of Use and Privacy Policy.